Stocks

Actinium Pharmaceuticals, Inc. (ATNM) and SCYNEXIS, Inc. (SCYX) Activist Update

Frigate Ventures LP has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,000,000 shares of Actinium Pharmaceuticals, Inc. (AMEX:ATNM). This represents 5.5 percent ownership of the company. Actinium Pharmaceuticals, Inc. has declared a standard industrial code (sic) of 2834 which is the “Pharmaceutical Preparations” industry.

Caxton Corp has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,870,409 shares of SCYNEXIS, Inc. (NASDAQ:SCYX). This represents 9.99 percent ownership of the company. SCYNEXIS, Inc. has declared a standard industrial code (sic) of 2834 which is the “Pharmaceutical Preparations” industry.

When a person or group of persons acquires beneficial ownership of more than 5% of a company’s equity securities, they are required to file a Schedule 13D or 13G with the SEC. If these groups intend to influence management into changing the business strategy, they are considered “activist” investors. There is considerable academic research that suggest activist investors contribute to excess returns in equities in the subsequent twelve months after the event.

Investors that acquire 10% or more of a company’s shares, or that gain a board seat, are considered insiders by the SEC and are subject to stricter insider trading filing requirements.

Amended Activist Investor Filings

Automatic Data Processing, Inc. (ADP) – Pershing Square Capital Management, L.P. has filed an amended Schedule 13D/A, reporting a 7.20% ownership stake in Automatic Data Processing. This is a decrease of 13.25% from their previous filing.

Mellanox Technologies, Ltd. (MLNX) – Starboard Value LP has filed an amended Schedule 13D/A, reporting a 10.60% ownership stake in Mellanox Technologies. This is a decrease of 0.93% from their previous filing.

MGM Resorts International (MGM) – Tracinda Corp has filed an amended Schedule 13D/A, reporting a 4.80% ownership stake in MGM Resorts International. This is a decrease of 27.05% from their previous filing.

Hilton Grand Vacations Inc. (HGV) – HNA Tourism Group Co., Ltd. has filed an amended Schedule 13D/A, reporting a 24.90% ownership stake in Hilton Grand Vacations. This is a decrease of 0.40% from their previous filing.

MSB Financial Corp. (MSBF) – Seidman Lawrence B has filed an amended Schedule 13D/A, reporting a 10.38% ownership stake in MSB Financial. This is a decrease of 18.59% from their previous filing.

Ingles Markets, Incorporated (IMKTA) – Gamco Investors, Inc. Et Al has filed an amended Schedule 13D/A, reporting a 8.24% ownership stake in Ingles Markets. This is a decrease of 4.30% from their previous filing.

WSI Industries, Inc. (WSCI) – Digital Power Corp has filed an amended Schedule 13D/A, reporting a 9.22% ownership stake in WSI Industries. This is an increase of 4.77% from their previous filing.

GAMCO Investors, Inc. (GBL) – Ggcp, Inc. has filed an amended Schedule 13D/A, reporting a 41.40% ownership stake in GAMCO Investors. This is a decrease of 8.81% from their previous filing.

Associated Capital Group, Inc. (AC.WD) – Ggcp, Inc. has filed an amended Schedule 13D/A, reporting a 81.80% ownership stake in Associated Capital Group. This is an increase of 3.54% from their previous filing.

Galena Biopharma, Inc. (GALE) – Equilibria Capital Management Ltd has filed an amended Schedule 13D/A, reporting a 48.20% ownership stake in Galena Biopharma. This is a decrease of 3.98% from their previous filing.

Autoliv, Inc. (ALV) – Cevian Capital II GP LTD has filed an amended Schedule 13D/A, reporting a 7.50% ownership stake in Autoliv.

Alteryx Inc. (AYX) – Insight Venture Partners VIII, L.P. has filed an amended Schedule 13D/A, reporting a 33.40% ownership stake in Alteryx. This is a decrease of 9.24% from their previous filing.

New Passive Investor Filings

Investors that acquire more than 5% of the shares of a company but have no intention of influencing management are considered passive investors and must file a 13G.

Can-Fite Biopharma Ltd. (CANF) – Sabby Management, LLC has filed a new SC 13G, reporting a 8.34% ownership stake in Can-Fite Biopharma. This is an increase of 67.13% from their previous filing.

SCYNEXIS, Inc. (SCYX) – Caxton Corp has filed a new SC 13G, reporting a 9.99% ownership stake in SCYNEXIS.

Actinium Pharmaceuticals, Inc. (ATNM) – Frigate Ventures LP has filed a new SC 13G, reporting a 5.50% ownership stake in Actinium Pharmaceuticals.

Dynagas LNG Partners LP (DLNG) – cobas asset management, sgiic, s.a. has filed a new SC 13G, reporting a 5.06% ownership stake in Dynagas LNG Partners.

Tokai Pharmaceuticals, Inc. (TKAI) – Lifesci Index Partners Llc has filed a new SC 13G, reporting a 12.24% ownership stake in Tokai Pharmaceuticals.

U.S. Auto Parts Network, Inc. (PRTS) – Calm Waters Partnership has filed a new SC 13G, reporting a 5.40% ownership stake in U.S. Auto Parts Network. This is an increase of 14.89% from their previous filing.

Wheeler Real Estate Investment Trust, Inc. (WHLR) – Calm Waters Partnership has filed a new SC 13G, reporting a 8.50% ownership stake in Wheeler Real Estate Investment Trust.

Amended Passive Investor Filings

Dreyfus Municipal Income Fund, Inc. (DMF) – Comerica Bank has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Dreyfus Municipal Income Fund. This is a decrease of 100.00% from their previous filing.

WildHorse Resource Development Corp (WRD) – KKR Fund Holdings L.P. has filed an amended Schedule 13D/A, reporting a 4.80% ownership stake in WildHorse Resource Development. This is a decrease of 12.73% from their previous filing.

Dreyfus Strategic Municipals, Inc. (LEO) – Comerica Bank has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Dreyfus Strategic Municipals. This is a decrease of 100.00% from their previous filing.

Old National Bancorp (ONB) – Gentwo, Lllp has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Old National Bancorp.

Fintel provides free investor tools for data driven investors. Get full coverage of FMR LLC / Fidelity or ADMS: Adamas Pharmaceuticals Analysis and Research Report.